Cancer Care Specialists of Illinois Welcomes Pramod Gaudel, MD
(Effingham, IL) – Cancer Care Specialists of Illinois (CCSI) is pleased to announce the addition of Dr. Pramod Gaudel, medical oncologist/hematologist, to its practice in July 2022. Dr. Gaudel primarily sees patients at Crossroads Cancer Center in Effingham. He also provides coverage at other CCSI clinics including Flora, Olney and Vandalia.
“Cancer Care is excited to welcome Gaudel to the Effingham community. Dr. Gaudel is joining Drs. Dy, Saba, and Duncan in the Crossroads Cancer Center and will be integral to the continued delivery of excellent cancer care to Effingham and the surrounding communities. Dr. Gaudel comes to us from an excellent fellowship program at the University of Kansas. CCSI and Effingham are very fortunate to have him in the community.” – Justin D. Floyd, DO, FACOI, President of Cancer Care Specialists of Illinois
Before joining CCSI, Dr. Gaudel was awarded the prestigious Laxmidas A. Sawkar Fellowship Award in 2022, while completing a second Fellowship in Hematology and Medical Oncology at the University of Kansas in Kansas City, Kansas. He is board certified in Internal Medicine and is board-eligible in Medical Oncology and Hematology. Dr. Gaudel is a member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), American Medical Association (AMA), American College of Physicians (ACP) and the Multinational Association for Supportive Care in Cancer (MASCC).
“I am thrilled to contribute to CCSI’s mission of providing the highest quality of cancer care, close to home in a warm and friendly community setting. I believe communication is essential for successful care. Each patient’s situation is unique and it is important to take a collaborative approach to create an individualized plan of care. It’s the same thing we would do if caring for a member of our family.” – Pramod Gaudel, MD.
Dr. Gaudel has special interests in thoracic oncology and genitourinary oncology. His research interests include immunotherapy and targeted therapy. He has authored and been published in the Journal of Clinical Oncology, Blood, Journal for ImmunoTherapy of Cancer, Federal Practitioner, The Cureus Journal of Medical Science and the Archives of Clinical and Medical Case Reports.
To learn more and read Dr. Gaudel’s complete bio, visit his profile page.
